Felix is a patient recovering from a history of opioid use disorder who visits the pharmacy daily for a methadone 15mg treatment.

MEET FELIX

  • Age: 28
  • Condition: Felix is in recovery for opioid use disorder.
  • Treatment plan: Felix visits his pharmacy daily for a methadone 15 mg treatment.
  • Other: According to his pharmacy record, Felix has missed two methadone doses this week.

 

 

References: 1. Alberta College of Pharmacists. Helping you navigate change: The communication issue. The Transition Times. October 2008. Available at: https://abpharmacy.ca/system/files/TransitionTimes_Oct08.pdf. Accessed September 2, 2021. 2. Antoniou T, Pritlove C, Shearer D, et al. A qualitative study of a publicly funded pharmacy-dispensed naloxone program. International Journal of Drug Policy. 2021:103146. 3. Government of Canada. Opioid overdose. Available at: https://www.canada.ca/en/health-canada/services/substance-use/problematic-prescription-drug-use/opioids/overdose.html. 4. Mueller SR et al. Attitudes toward naloxone prescribing in clinical settings: a qualitative study of patients prescribed high dose opioids for chronic non-cancer pain. Gen Intern Med. 2016;32(3):277-283. 5. Tsuyuki R et al.. Canadian national consensus guidelines for naloxone prescribing by pharmacists. Canadian Pharmacists Journal. 2020;153(6):347-351.



PP-NAR4-CA-00087_05-2024 EN

Distributed by Emergent BioSolutions Canada Inc. Mississauga, ON L5N 6M1.

© 2025 Emergent BioSolutions Canada Inc., a wholly owned subsidiary of Emergent BioSolutions Inc.
NARCAN® is a registered trademark of Emergent Operations Ireland Limited, which is a subsidiary of Emergent BioSolutions Inc.

EMERGENT® and any and all Emergent BioSolutions Inc. brands, products, services and feature names, logos and slogans are trademarks or registered trademarks of Emergent BioSolutions Inc. or its
subsidiaries in the United States or other countries.